Loading...

PTIX PROTAGENIC THERAPEUTICS INC Capital Structure Changes 8-K Filing

PRTG

PTX

PROTAGENIC THERAPEUTICS INC

(PTIX)

2025 8-K

Delisting Notification

Director Resignation

Legal Action Filed

Acquisition Update

Company Acquisition

Accounting Changes

Restructuring Plan

Rights Offerings

Warrant Exercises

Warrant Exchange

Asset Acquisitions

Stock Split Approval

Stock Option Repricing

Annual Meeting Results

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Update

Filing with Quantitative Data

Quantitative Data

Annual Meeting Results

Quantitative Data

Reverse Stock Split

External Links:

Protagenic Therapeutics, Inc. has amended its sales agreement with B. Riley Securities to potentially sell up to $1,200,000 worth of common stock at market prices, with a 3% commission for the agent.

AI Assistant

PROTAGENIC THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.